Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

Phase 2 Completed 67 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Ortho Biotech Products, L.P. · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the hemoglobin response rate in subjects with anemia, associated with chronic kidney failure, after receiving epoetin alfa (PROCRITÂ®) every 2 weeks

Timeline

Start: 2004-05
Primary completion: —
Completion: 2005-10

Publications

Results Benz R, Schmidt R, Kelly K, Wolfson M. Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease. Clin J Am Soc Nephrol. 2007 Mar;2(2):215-21. doi: 10.2215/CJN.02590706. Epub 2007 Jan 10.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	epoetin alfa	Protein / enzyme biologic	20000 iu	Subcutaneous

Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

Summary

Timeline

Publications

Drugs

Indications